• Return to Headlines

Loxo Oncology In Has Returned 1.0% Since SmarTrend Recommendation (LOXO)

By Amy Schwartz

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 9 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66.

Over the past year, Loxo Oncology In has traded in a range of $125.00 to $234.93 and is now at $234.66, 88% above that low. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has remained constant.

Loxo Oncology, Inc. researches and develops cancer drugs. The company focuses on building small molecule cancer drugs for genetically defined patient subsets.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Loxo Oncology In shares.

Log in and add Loxo Oncology In (LOXO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights loxo oncology in

Ticker(s): LOXO